This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (37)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Oncology  • Cervical Cancer  • Dermatology  • Dermatologic Disorders  • Papillomavirus, Human  • Alert me on articles by topic  Social Bookmarking   What's this?

Jack Cuzick, PhD

JAMA. 2000;283:108-109.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The human papillomavirus (HPV) has been clearly established as the primary cause of cervical cancer in nearly all cases.¹ Thus, it should not be surprising that testing for HPV should have a role in measures aimed at control of this disease. The ultimate goal must be eradication of HPV by vaccination, but a more immediate prospect is the detection and monitoring of the virus as part of the screening and diagnostic process. Testing for HPV could have 3 potential roles: triage of patients with atypical squamous cells of undetermined significance (ASCUS) and low-grade cervical smears; surveillance of high-grade cervical intraepithelial neoplasia and localized (micro) invasive disease after treatment; and primary screening—either alone or in combination with cytology.

This third area is the most far-reaching and 2 articles in this issue of THE JOURNAL^2-3 make important contributions to its evaluation. The potential role of HPV testing in cervical . . . [Full Text of this Article]

Author Affiliation: Department of Mathematics, Statistics, and Epidemiology, Imperial Cancer Research Fund, London, England.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

HPV DNA Testing of Self-collected Vaginal Samples Compared With Cytologic Screening to Detect Cervical Cancer
Thomas C. Wright, Jr, Lynette Denny, Louise Kuhn, Amy Pollack, and Attila Lorincz
JAMA. 2000;283(1):81-86.
ABSTRACT | FULL TEXT  

HPV DNA Testing in Cervical Cancer Screening: Results From Women in a High-Risk Province of Costa Rica
Mark Schiffman, Rolando Herrero, Allan Hildesheim, Mark E. Sherman, Maria Bratti, Sholom Wacholder, Mario Alfaro, Martha Hutchinson, Jorge Morales, Mitchell D. Greenberg, and Attila T. Lorincz
JAMA. 2000;283(1):87-93.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area
Speich et al.
J Med Microbiol 2004;53:125-128.
ABSTRACT | FULL TEXT  

Factors Affecting the Detection Rate of Human Papillomavirus
Harper et al.
Ann Fam Med 2003;1:221-227.
ABSTRACT | FULL TEXT  

Novel Method for Detection, Typing, and Quantification of Human Papillomaviruses in Clinical Samples
Hart et al.
J. Clin. Microbiol. 2001;39:3204-3212.
ABSTRACT | FULL TEXT  

What we could do now: molecular pathology of gynaecological cancer
Herrington
Mol. Pathol. 2001;54:222-224.
ABSTRACT | FULL TEXT  

A higher level of human papillomavirus 16 DNA was associated with an increased risk for cervical carcinoma in situ
Melnikow and Nuovo
Evid. Based Med. 2001;6:29-29.
FULL TEXT  

Persistently high loads of human papillomavirus 16 over time were associated with an increased risk for cervical cancer
Melnikow and Nuovo
Evid. Based Med. 2001;6:30-30.
FULL TEXT